BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Liu W, Wang S, Sun Q, Yang Z, Liu M, Tang H. DCLK1 promotes epithelial-mesenchymal transition via the PI3K/Akt/NF-κB pathway in colorectal cancer.Int J Cancer. 2018;142:2068-2079. [PMID: 29277893 DOI: 10.1002/ijc.31232] [Cited by in Crossref: 38] [Cited by in F6Publishing: 39] [Article Influence: 9.5] [Reference Citation Analysis]
Number Citing Articles
1 He T, Shen H, Wang S, Wang Y, He Z, Zhu L, Du X, Wang D, Li J, Zhong S, Huang W, Yang H. MicroRNA-3613-5p Promotes Lung Adenocarcinoma Cell Proliferation through a RELA and AKT/MAPK Positive Feedback Loop. Mol Ther Nucleic Acids 2020;22:572-83. [PMID: 33230458 DOI: 10.1016/j.omtn.2020.09.024] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
2 Zhou M, Li J, Luo D, Zhang H, Yu Z, Chen Y, Li Q, Liang F, Chen R. Network Pharmacology and Molecular Docking-Based Investigation: Prunus mume Against Colorectal Cancer via Silencing RelA Expression. Front Pharmacol 2021;12:761980. [PMID: 34867383 DOI: 10.3389/fphar.2021.761980] [Reference Citation Analysis]
3 Yang Y, Ma L, Xu Y, Liu Y, Li W, Cai J, Zhang Y. Enalapril overcomes chemoresistance and potentiates antitumor efficacy of 5-FU in colorectal cancer by suppressing proliferation, angiogenesis, and NF-κB/STAT3-regulated proteins. Cell Death Dis 2020;11:477. [PMID: 32581212 DOI: 10.1038/s41419-020-2675-x] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 7.0] [Reference Citation Analysis]
4 Lu Y, Maruyama J, Kuwata K, Fukuda H, Iwasa H, Arimoto-Matsuzaki K, Sugimura H, Hata Y. Doublecortin-like kinase 1 compromises DNA repair and induces chromosomal instability. Biochem Biophys Rep 2018;16:130-7. [PMID: 30417131 DOI: 10.1016/j.bbrep.2018.10.014] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
5 Zhang N, Chen X. A positive feedback loop involving the LINC00346/β-catenin/MYC axis promotes hepatocellular carcinoma development. Cell Oncol 2020;43:137-53. [DOI: 10.1007/s13402-019-00478-4] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
6 Wang L, Jiang F, Ma F, Zhang B. MiR-873-5p suppresses cell proliferation and epithelial-mesenchymal transition via directly targeting Jumonji domain-containing protein 8 through the NF-κB pathway in colorectal cancer. J Cell Commun Signal 2019;13:549-60. [PMID: 31152315 DOI: 10.1007/s12079-019-00522-w] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 5.7] [Reference Citation Analysis]
7 Makino S, Takahashi H, Okuzaki D, Miyoshi N, Haraguchi N, Hata T, Matsuda C, Yamamoto H, Mizushima T, Mori M, Doki Y. DCLK1 integrates induction of TRIB3, EMT, drug resistance and poor prognosis in colorectal cancer. Carcinogenesis 2020;41:303-12. [DOI: 10.1093/carcin/bgz157] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
8 Wang L, Jiang F, Xia X, Zhang B. LncRNA FAL1 promotes carcinogenesis by regulation of miR-637/NUPR1 pathway in colorectal cancer. The International Journal of Biochemistry & Cell Biology 2019;106:46-56. [DOI: 10.1016/j.biocel.2018.09.015] [Cited by in Crossref: 23] [Cited by in F6Publishing: 25] [Article Influence: 7.7] [Reference Citation Analysis]
9 Fu J, Xu Y, Yang Y, Liu Y, Ma L, Zhang Y. Aspirin suppresses chemoresistance and enhances antitumor activity of 5-Fu in 5-Fu-resistant colorectal cancer by abolishing 5-Fu-induced NF-κB activation. Sci Rep 2019;9:16937. [PMID: 31729451 DOI: 10.1038/s41598-019-53276-1] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
10 Liu Y, Ferguson FM, Li L, Kuljanin M, Mills CE, Subramanian K, Harshbarger W, Gondi S, Wang J, Sorger PK, Mancias JD, Gray NS, Westover KD. Chemical Biology Toolkit for DCLK1 Reveals Connection to RNA Processing. Cell Chem Biol 2020;27:1229-1240.e4. [PMID: 32755567 DOI: 10.1016/j.chembiol.2020.07.011] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
11 Liang X, Gao J, Wang Q, Hou S, Wu C. ECRG4 Represses Cell Proliferation and Invasiveness via NFIC/OGN/NF-κB Signaling Pathway in Bladder Cancer. Front Genet 2020;11:846. [PMID: 32922434 DOI: 10.3389/fgene.2020.00846] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
12 Zhao Y, Zhang H, Ju Q, Li X, Zheng Y. Comprehensive Analysis of Survival-Related lncRNAs, miRNAs, and mRNAs Forming a Competing Endogenous RNA Network in Gastric Cancer. Front Genet 2021;12:610501. [PMID: 33737947 DOI: 10.3389/fgene.2021.610501] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
13 Wang H, Jiang F, Liu W, Tian W. miR-595 suppresses cell proliferation and metastasis in hepatocellular carcinoma by inhibiting NF-κB signalling pathway. Pathol Res Pract 2020;216:152899. [PMID: 32107085 DOI: 10.1016/j.prp.2020.152899] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
14 Narayanankutty A. PI3K/ Akt/ mTOR Pathway as a Therapeutic Target for Colorectal Cancer: A Review of Preclinical and Clinical Evidence. CDT 2019;20:1217-26. [DOI: 10.2174/1389450120666190618123846] [Cited by in Crossref: 32] [Cited by in F6Publishing: 35] [Article Influence: 10.7] [Reference Citation Analysis]
15 Liu QX, Wang XM, Lv JJ, Lu Y, Zhao Y, Fan XP. Knockdown of long non-coding RNA TPT1-AS1 inhibits invasion and migration of hepatocarcinoma cells. Shijie Huaren Xiaohua Zazhi 2021; 29(7): 340-346 [DOI: 10.11569/wcjd.v29.i7.340] [Reference Citation Analysis]
16 Yan R, Li J, Zhou Y, Yao L, Sun R, Xu Y, Ge Y, An G. Inhibition of DCLK1 down-regulates PD-L1 expression through Hippo pathway in human pancreatic cancer. Life Sciences 2020;241:117150. [DOI: 10.1016/j.lfs.2019.117150] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
17 Jiang L, Chen Y, Min G, Wang J, Chen W, Wang H, Wang X, Yao N. Bcl2-associated athanogene 4 promotes the invasion and metastasis of gastric cancer cells by activating the PI3K/AKT/NF-κB/ZEB1 axis. Cancer Lett 2021;520:409-21. [PMID: 34419501 DOI: 10.1016/j.canlet.2021.08.020] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
18 Li O, Zhao C, Zhang J, Li FN, Yang ZY, Liu SL, Cai C, Jia ZY, Gong W, Shu YJ, Dong P. UBAP2L promotes gastric cancer metastasis by activating NF-κB through PI3K/AKT pathway. Cell Death Discov 2022;8:123. [PMID: 35304439 DOI: 10.1038/s41420-022-00916-7] [Reference Citation Analysis]
19 Wang YP, Zhao YJ, Kong XL. A metalloproteinase of the disintegrin and metalloproteinases and the ThromboSpondin Motifs 6 as a novel marker for colon cancer: functional experiments. Genet Mol Biol 2020;43:e20190266. [PMID: 33063817 DOI: 10.1590/1678-4685-GMB-2019-0266] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
20 Yang WQ, Zhao WJ, Zhu LL, Xu SJ, Zhang XL, Liang Y, Ding XF, Kiselyov A, Chen G. XMD-17-51 Inhibits DCLK1 Kinase and Prevents Lung Cancer Progression. Front Pharmacol 2021;12:603453. [PMID: 33762936 DOI: 10.3389/fphar.2021.603453] [Reference Citation Analysis]
21 Broner EC, Trujillo JA, Korzinkin M, Subbannayya T, Agrawal N, Ozerov IV, Zhavoronkov A, Rooper L, Kotlov N, Shen L, Pearson AT, Rosenberg AJ, Savage PA, Mishra V, Chatterjee A, Sidransky D, Izumchenko E. Doublecortin-Like Kinase 1 (DCLK1) Is a Novel NOTCH Pathway Signaling Regulator in Head and Neck Squamous Cell Carcinoma. Front Oncol 2021;11:677051. [PMID: 34336664 DOI: 10.3389/fonc.2021.677051] [Reference Citation Analysis]
22 Tian H, Wang X, Lu J, Tian W, Chen P. MicroRNA-621 inhibits cell proliferation and metastasis in bladder cancer by suppressing Wnt/β-catenin signaling. Chem Biol Interact 2019;308:244-51. [PMID: 31145890 DOI: 10.1016/j.cbi.2019.05.042] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.7] [Reference Citation Analysis]
23 Liu JY, Jiang L, He T, Liu JJ, Fan JY, Xu XH, Tang B, Shi Y, Zhao YL, Qian F, Wang Y, Cui YH, Yu PW. NETO2 promotes invasion and metastasis of gastric cancer cells via activation of PI3K/Akt/NF-κB/Snail axis and predicts outcome of the patients. Cell Death Dis 2019;10:162. [PMID: 30770791 DOI: 10.1038/s41419-019-1388-5] [Cited by in Crossref: 24] [Cited by in F6Publishing: 27] [Article Influence: 8.0] [Reference Citation Analysis]
24 Reineking W, Schauerte IE, Junginger J, Hewicker-trautwein M. Sox9, Hopx, and survivin and tuft cell marker DCLK1 expression in normal canine intestine and in intestinal adenoma and adenocarcinoma. Vet Pathol. [DOI: 10.1177/03009858221079666] [Reference Citation Analysis]
25 Yang Y, Zhang M, Jin C, Ding Y, Yang M, Wang R, Zhou Y, Zhou Y, Li T, Wang K, Hu R. Absent in melanoma 2 suppresses epithelial-mesenchymal transition via Akt and inflammasome pathways in human colorectal cancer cells. J Cell Biochem 2019;120:17744-56. [PMID: 31210372 DOI: 10.1002/jcb.29040] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
26 Ge P, Cao L, Zheng M, Yao Y, Wang W, Chen X. LncRNA SNHG1 contributes to the cisplatin resistance and progression of NSCLC via miR-330-5p/DCLK1 axis. Exp Mol Pathol 2021;120:104633. [PMID: 33753110 DOI: 10.1016/j.yexmp.2021.104633] [Reference Citation Analysis]
27 Deng XT, Tang SM, Wu PY, Li QP, Ge XX, Xu BM, Wang HS, Miao L. SP/NK-1R promotes gallbladder cancer cell proliferation and migration. J Cell Mol Med 2019;23:7961-73. [PMID: 30903649 DOI: 10.1111/jcmm.14230] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
28 Shen Y, Wang C, Ren Y, Ye J. A comprehensive look at the role of hyperlipidemia in promoting colorectal cancer liver metastasis. J Cancer 2018;9:2981-6. [PMID: 30123367 DOI: 10.7150/jca.25640] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
29 Zhuang R, Zhang X, Lu D, Wang J, Zhuo J, Wei X, Ling Q, Xie H, Zheng S, Xu X. lncRNA DRHC inhibits proliferation and invasion in hepatocellular carcinoma via c-Myb-regulated MEK/ERK signaling. Mol Carcinog 2019;58:366-75. [PMID: 30362626 DOI: 10.1002/mc.22934] [Cited by in Crossref: 6] [Cited by in F6Publishing: 11] [Article Influence: 1.5] [Reference Citation Analysis]
30 Li J, Peng W, Yang P, Chen R, Gu Q, Qian W, Ji D, Wang Q, Zhang Z, Tang J, Sun Y. MicroRNA-1224-5p Inhibits Metastasis and Epithelial-Mesenchymal Transition in Colorectal Cancer by Targeting SP1-Mediated NF-κB Signaling Pathways. Front Oncol 2020;10:294. [PMID: 32231999 DOI: 10.3389/fonc.2020.00294] [Cited by in Crossref: 12] [Cited by in F6Publishing: 15] [Article Influence: 6.0] [Reference Citation Analysis]
31 Bai Z, Xia X, Lu J. MicroRNA-639 is Down-Regulated in Hepatocellular Carcinoma Tumor Tissue and Inhibits Proliferation and Migration of Human Hepatocellular Carcinoma Cells Through the KAT7/Wnt/β-Catenin Pathway. Med Sci Monit 2020;26:e919241. [PMID: 31955177 DOI: 10.12659/MSM.919241] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
32 Vijai M, Baba M, Ramalingam S, Thiyagaraj A. DCLK1 and its interaction partners: An effective therapeutic target for colorectal cancer. Oncol Lett 2021;22:850. [PMID: 34733368 DOI: 10.3892/ol.2021.13111] [Reference Citation Analysis]
33 Lai T, Qiu H, Si L, Zhen Y, Chu D, Guo R. Long noncoding RNA BMPR1B-AS1 facilitates endometrial cancer cell proliferation and metastasis by sponging miR-7-2-3p to modulate the DCLK1/Akt/NF-κB pathway. Cell Cycle 2022;:1-20. [PMID: 35404759 DOI: 10.1080/15384101.2022.2060003] [Reference Citation Analysis]
34 Carli ALE, Afshar-Sterle S, Rai A, Fang H, O'Keefe R, Tse J, Ferguson FM, Gray NS, Ernst M, Greening DW, Buchert M. Cancer stem cell marker DCLK1 reprograms small extracellular vesicles toward migratory phenotype in gastric cancer cells. Proteomics 2021;21:e2000098. [PMID: 33991177 DOI: 10.1002/pmic.202000098] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
35 Testa U, Pelosi E, Castelli G. Colorectal cancer: genetic abnormalities, tumor progression, tumor heterogeneity, clonal evolution and tumor-initiating cells. Med Sci (Basel) 2018;6:E31. [PMID: 29652830 DOI: 10.3390/medsci6020031] [Cited by in Crossref: 47] [Cited by in F6Publishing: 70] [Article Influence: 11.8] [Reference Citation Analysis]
36 Liu Y, Wang D, Lei M, Gao J, Cui Y, Jin X, Yu Q, Jiang Y, Guo Y, Liu Y, Cai L, Chen X. GABARAP suppresses EMT and breast cancer progression via the AKT/mTOR signaling pathway. Aging (Albany NY) 2021;13:5858-74. [PMID: 33591943 DOI: 10.18632/aging.202510] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
37 Wu Y, Ma Y, Li J, Zhou XL, Li L, Xu PX, Li XR, Xue M. The bioinformatics and metabolomics research on anti-hypoxic molecular mechanisms of Salidroside via regulating the PTEN mediated PI3K/Akt/NF-κB signaling pathway. Chin J Nat Med 2021;19:442-53. [PMID: 34092295 DOI: 10.1016/S1875-5364(21)60043-2] [Reference Citation Analysis]
38 Zhang Y, Qi X, Chen X, Zhang J, Zhang W, Lin H. Dietary selenomethionine ameliorates lipopolysaccharide-induced renal inflammatory injury in broilers via regulating the PI3K/AKT pathway to inhibit necroptosis. Food Funct 2021;12:4392-401. [PMID: 33908541 DOI: 10.1039/d1fo00424g] [Reference Citation Analysis]
39 Zhang L, Zhou S, Guo E, Chen X, Yang J, Li X. DCLK1 inhibition attenuates tumorigenesis and improves chemosensitivity in esophageal squamous cell carcinoma by inhibiting β-catenin/c-Myc signaling. Pflugers Arch 2020;472:1041-9. [PMID: 32533239 DOI: 10.1007/s00424-020-02415-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
40 Li B, Mao R, Liu C, Zhang W, Tang Y, Guo Z. LncRNA FAL1 promotes cell proliferation and migration by acting as a CeRNA of miR-1236 in hepatocellular carcinoma cells. Life Sci 2018;197:122-9. [PMID: 29421439 DOI: 10.1016/j.lfs.2018.02.006] [Cited by in Crossref: 85] [Cited by in F6Publishing: 94] [Article Influence: 21.3] [Reference Citation Analysis]
41 Xu L, Wang P, Feng X, Tang J, Li L, Zheng X, Zhang J, Hu Y, Lan T, Yuan K, Zhang Y, Ren S, Hao X, Zhang M, Xu M. SETD3 is regulated by a couple of microRNAs and plays opposing roles in proliferation and metastasis of hepatocellular carcinoma. Clin Sci (Lond) 2019;133:2085-105. [PMID: 31654063 DOI: 10.1042/CS20190666] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
42 Li Y, Lv Y, Cheng C, Huang Y, Yang L, He J, Tao X, Hu Y, Ma Y, Su Y, Wu L, Yu G, Jiang Q, Liu S, Liu X, Liu Z. SPEN induces miR-4652-3p to target HIPK2 in nasopharyngeal carcinoma. Cell Death Dis 2020;11:509. [PMID: 32641685 DOI: 10.1038/s41419-020-2699-2] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
43 Cheng Z, Zhang Y, Wu S, Zhao R, Yu Y, Zhou Y, Zhou Z, Dong Y, Qiu A, Xu H, Liu Y, Zhang W, Tian T, Wu Q, Gu H, Chu M. Peripheral blood circular RNA hsa_circ_0058493 as a potential novel biomarker for silicosis and idiopathic pulmonary fibrosis. Ecotoxicology and Environmental Safety 2022;236:113451. [DOI: 10.1016/j.ecoenv.2022.113451] [Reference Citation Analysis]
44 Lou HF, Ma CM, Fu YZ, Zhang S. Relationship between Helicobacter pylori infection and epithelial-mesenchymal transition in colorectal cancer. Shijie Huaren Xiaohua Zazhi 2021; 29(15): 858-865 [DOI: 10.11569/wcjd.v29.i15.858] [Reference Citation Analysis]
45 Ge Y, Liu H, Zhang Y, Liu J, Yan R, Xiao Z, Fan X, Huang X, An G. Inhibition of DCLK1 kinase reverses epithelial-mesenchymal transition and restores T-cell activity in pancreatic ductal adenocarcinoma. Transl Oncol 2022;17:101317. [PMID: 34998236 DOI: 10.1016/j.tranon.2021.101317] [Reference Citation Analysis]
46 Zhang Z, Li H, You J, Xue H, Tan X, Chao C. MicroRNA-223-5p suppresses the progression of nasopharyngeal carcinoma by targeting DCLK1. Oncol Lett 2021;21:396. [PMID: 33777219 DOI: 10.3892/ol.2021.12657] [Reference Citation Analysis]
47 Lorenzo N, Sabina DM, Guido C, Ilaria Grazia Z, Samira S, Valeria A, Daniele C, Diletta O, Antonella G, Marco M, Daniela B, Valerio P, Andrea O, Agostino Maria R, Fabio M, Maria Consiglia B, Jessica F, Sara M, Gian Luca G, Pierluigi Benedetti P, Paquale Bartomeo B, Felice G, Vincenzo C, Pietro I, Giuseppina C, Eugenio G, Domenico A. DCLK1, a Putative Stem Cell Marker in Human Cholangiocarcinoma. Hepatology 2021;73:144-59. [PMID: 32978808 DOI: 10.1002/hep.31571] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
48 Cao Z, Weygant N, Chandrakesan P, Houchen CW, Peng J, Qu D. Tuft and Cancer Stem Cell Marker DCLK1: A New Target to Enhance Anti-Tumor Immunity in the Tumor Microenvironment. Cancers (Basel) 2020;12:E3801. [PMID: 33348546 DOI: 10.3390/cancers12123801] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]